🔎 Trials Near Me

Utama › Leukemia Mieloid Akut › Virginia › Richmond

Kajian klinikal Leukemia Mieloid Akut di Richmond, VA

12 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar Richmond (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Mengambil pesertaFasa 2
  • VCU Massey Comprehensive Cancer Center, Richmond
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Bon Secours Richmond Community Hospital, Richmond
  • Bon Secours Saint Mary's Hospital, Richmond
  • Bon Secours Cancer Institute at Reynolds Crossing, Richmond
  • dan 3 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Mengambil pesertaFasa 3
  • Virginia Commonwealth University - Massey Cancer Center, Richmond
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Mengambil pesertaFasa 2
  • VCU Massey Comprehensive Cancer Center, Richmond
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06672146

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Mengambil pesertaFasa 2
  • VCU Massey Comprehensive Cancer Center, Richmond
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06317649

Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

Mengambil pesertaFasa 2
  • Virginia Commonwealth University, Richmond
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07710534

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Mengambil pesertaFasa 3
  • VCU Massey Comprehensive Cancer Center, Richmond
6 Months – 21 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04293562

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Mengambil pesertaFasa 3
  • Children's Hospital of Richmond at Virginia Commonwealth University, Richmond
29 Days – 21 Years · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05183035

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Mengambil pesertaKajian pemerhatian
  • Virginia Commonwealth University, Richmond
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Mengambil pesertaFasa 4
  • Virginia Commonwealth University, Richmond
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Mei 2026 · NCT06370000

Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation

Mengambil pesertaFasa 1
  • Virginia Commonwealth University, Richmond
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Feb 2026 · NCT07130695

Kajian Leukemia Mieloid Akut di bandar lain

Kajian lain di Richmond

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.